Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · IEX Real-Time Price · USD
1.050
-0.010 (-0.94%)
At close: Apr 30, 2024, 3:57 PM
1.160
+0.110 (10.48%)
After-hours: Apr 30, 2024, 6:39 PM EDT
Estrella Immunopharma Market Cap
Estrella Immunopharma has a market cap or net worth of $38.44 million as of April 30, 2024. Its market cap has decreased by -38.50% in one year.
Market Cap
38.44M
Enterprise Value
29.39M
1-Year Change
-38.50%
Ranking
Category
Stock Price
$1.05
Market Cap Chart
Since July 15, 2021, Estrella Immunopharma's market cap has decreased from $52.70M to $38.44M, a decrease of -27.06%. That is a compound annual growth rate of -10.69%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 29, 2024 | 39.10M | 4.83% |
Apr 26, 2024 | 37.30M | -2.10% |
Apr 25, 2024 | 38.10M | -7.07% |
Apr 24, 2024 | 41.00M | 8.75% |
Apr 23, 2024 | 37.70M | -3.33% |
Apr 22, 2024 | 39.00M | -0.51% |
Apr 19, 2024 | 39.20M | 3.98% |
Apr 18, 2024 | 37.70M | -8.05% |
Apr 17, 2024 | 41.00M | 3.27% |
Apr 16, 2024 | 39.70M | 2.32% |
Apr 15, 2024 | 38.80M | -6.28% |
Apr 12, 2024 | 41.40M | 3.76% |
Apr 11, 2024 | 39.90M | -7.64% |
Apr 10, 2024 | 43.20M | 10.20% |
Apr 9, 2024 | 39.20M | -2.73% |
Apr 8, 2024 | 40.30M | -4.28% |
Apr 5, 2024 | 42.10M | 0.96% |
Apr 4, 2024 | 41.70M | -6.71% |
Apr 3, 2024 | 44.70M | -0.67% |
Apr 2, 2024 | 45.00M | -2.39% |
Apr 1, 2024 | 46.10M | 1.54% |
Mar 28, 2024 | 45.40M | -0.87% |
Mar 27, 2024 | 45.80M | -0.65% |
Mar 26, 2024 | 46.10M | 11.35% |
Mar 25, 2024 | 41.40M | -1.66% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
ReWalk Robotics | 40.53M |
Incannex Healthcare | 39.99M |
ImmuCell | 39.53M |
Apollomics | 39.38M |
iCAD, Inc. | 39.28M |
SAB Biotherapeutics | 38.65M |
Carmell Therapeutics | 38.49M |
Owlet | 38.46M |